high
throughput
screen
render
new
inhibitor
eukaryot
protein
synthesi
one
molecul
report
select
block
initi
factor
investig
action
inhibitor
translat
direct
sever
viral
mrna
principl
util
found
inhibit
translat
direct
polioviru
ire
rabbit
reticulocyt
lysat
similar
extent
cap
mrna
moreov
inhibit
translat
driven
polioviru
ire
vitro
cultur
cell
despit
cleavag
picornaviru
proteas
final
translat
vesicular
stomat
viru
mrna
sindbi
viru
subgenom
mrna
block
infect
cell
similar
extent
cellular
mrna
find
cast
doubt
select
action
inhibitor
suggest
molecul
may
affect
step
protein
synthesi
unrel
cap
recognit
initi
protein
synthesi
complex
process
major
target
regul
gene
express
translat
level
two
major
mechan
initi
mrna
translat
known
eukaryot
cell
capdepend
intern
ribosom
entri
site
ire
driven
translat
first
one
mechan
involv
recognit
methyl
cap
structur
gpppn
locat
end
eukaryot
mrna
initi
factor
togeth
form
multiprotein
complex
jackson
et
al
sonenberg
hinnebusch
bind
complex
cap
structur
interact
small
ribosom
subunit
contain
sever
initi
factor
eif
promot
initi
mettrna
met
interact
togeth
gtp
form
ternari
complex
locat
close
p
site
ribosom
subunit
bind
middl
domain
establish
interact
preiniti
complex
end
mrna
bear
cap
structur
lorsch
dever
afterward
subunit
scan
region
utr
mrna
aug
initi
codon
found
within
good
initi
context
hinnebusch
valasek
secondari
structur
utr
melt
scan
process
part
helicas
activ
parsyan
et
al
complex
repres
key
target
regul
translat
particularli
interact
take
place
motif
sequenc
x
x
variabl
f
hydrophob
mader
et
al
morino
et
al
ratelimit
factor
complex
whose
involv
translat
regul
pathway
maman
et
al
activ
control
sever
protein
abl
bind
factor
ie
bind
protein
interact
regul
mtor
pathway
induc
phosphoryl
block
manner
interact
leav
free
bind
thu
interact
site
overlap
marcotrigiano
et
al
richter
sonenberg
contrast
capdepend
translat
process
iresdriven
protein
synthesi
requir
recognit
cap
structur
end
initi
take
place
direct
interact
ribosom
subunit
even
ribosom
intern
region
utr
locat
upstream
aug
initi
codon
belsham
fitzgerald
semler
picornavirus
encephalomyocard
viru
emcv
polioviru
pv
mrna
contain
cap
structur
therefor
requir
initi
translat
instead
ctermin
twothird
bound
necessari
initi
translat
picornaviru
mrna
anim
virus
contain
cap
mrna
may
requir
translat
infect
cell
case
vesicular
stomat
viru
vsv
mrna
connor
lyle
welnowska
et
al
sindbi
viru
sv
subgenom
mrna
sgmrna
castello
et
al
sanz
et
al
select
inhibitor
protein
synthesi
proven
use
tool
help
unravel
exact
mechan
mrna
translat
vazquez
classic
inhibitor
deriv
natur
compound
recent
year
eleg
sophist
screen
method
use
identifi
inhibitor
initi
step
translat
cencic
et
al
moerk
et
al
novac
et
al
high
throughput
screen
small
molecul
librari
provid
novel
molecul
select
block
interact
one
molecul
identifi
inhibitor
capdepend
translat
interfer
bind
also
paradox
increas
interact
moerk
et
al
commerci
avail
compound
employ
sever
laboratori
analyz
biolog
process
relat
protein
synthesi
exampl
impair
longterm
associ
memori
consolid
hoeffer
et
al
hoeffer
et
al
may
provid
benefici
effect
autisticlik
behavior
observ
mice
furthermor
eif
overexpress
activ
sever
human
cancer
inhibit
translat
induc
apoptosismedi
cell
death
number
myeloma
cell
line
descamp
et
al
addit
shown
inhibit
growth
human
breast
melanoma
cancer
xenograft
without
appar
toxic
chen
et
al
howev
abrog
growth
induc
apoptosi
human
lung
cancer
cell
mechan
independ
interfer
capdepend
translat
fan
et
al
protein
synthesi
cultur
cell
strongli
reduc
lead
accumul
ribosom
phenomenon
observ
deplet
moka
et
al
thorough
studi
action
protein
synthesi
demonstr
inhibit
translat
compound
unrel
interfer
interact
mcmahon
et
al
thu
mtor
inhibitor
partial
block
overal
translat
primari
human
cell
disrupt
bind
wherea
potent
block
cellular
protein
synthesi
without
interf
complex
notabl
inhibit
readili
revers
even
prolong
incub
sever
day
despit
fact
protein
synthesi
strongli
diminish
addit
potent
block
poxviru
replic
well
reactiv
lytic
phase
herpesviru
infect
mcmahon
et
al
present
work
test
efficaci
inhibit
viral
mrna
translat
curious
vsv
sv
protein
synthesi
employ
inhibit
similar
extent
cellular
mrna
translat
addit
pv
ire
driven
translat
also
block
even
cleavag
pv
pro
find
demonstr
inhibit
translat
even
process
independ
thought
select
inhibitor
translat
initi
factor
test
efficaci
differ
mrna
templat
initi
action
molecul
assay
translat
capluc
pv
ire
luc
emcv
ire
luc
crpv
igrluc
mrna
principl
capluc
requir
translat
mrna
rrl
program
mrna
thu
incub
presenc
increas
concentr
assay
synthesi
luciferas
protein
shown
fig
synthesi
luciferas
direct
capluc
mrna
sensit
reduct
translat
greater
reduct
contrast
translat
direct
mrna
bear
emcv
ire
crpv
igr
resist
howev
signific
reduct
translat
approxim
interestingli
crpv
igr
translat
requir
canon
eif
deniz
et
al
wilson
et
al
partial
inhibit
translat
unexpect
probabl
rather
high
concentr
use
interfer
translat
process
independ
initi
surprisingli
luciferas
synthesi
direct
pv
ire
luc
mrna
sensit
inhibit
capluc
mrna
fig
inhibit
previous
suggest
partial
inhibit
emcv
iresdriven
translat
may
due
fact
mrna
use
complex
translat
inhibit
bind
may
alter
function
complex
devoid
moerk
et
al
test
possibl
analyz
effect
cleavag
picornaviru
proteas
well
establish
emcv
pv
iress
effici
translat
cleav
picornaviru
proteas
pro
l
pro
castello
et
al
gingra
et
al
condit
ntermin
moieti
interact
particip
translat
therefor
protein
synthesi
direct
mrna
bear
picornaviru
iress
employ
cleavag
expect
pretreat
rrl
fmdv
l
pro
hrv
pro
led
cleavag
fig
b
lower
panel
condit
translat
direct
pv
ire
luc
mrna
inhibit
similar
extent
remain
intact
fig
b
therefor
blockad
pv
ire
luc
mrna
translat
compound
due
lack
interact
control
examin
integr
stabil
pv
ire
luc
mrna
presenc
end
rna
extract
incub
pv
ire
luc
mrna
differ
concentr
compound
rrl
integr
extract
pv
ire
luc
mrna
measur
quantit
rtpcr
togeth
capac
direct
luciferas
synthesi
rrl
absenc
inhibitor
unaffect
incub
data
shown
thu
affect
stabil
function
pv
ire
luc
cell
free
system
analyz
activ
cell
differ
mrna
next
individu
transfect
fibroblast
transfect
carri
h
follow
medium
exchang
addit
min
incub
experiment
condit
translat
capluc
emc
ire
luc
pv
ire
luc
mrna
inhibit
approxim
crpv
igrluc
mrna
inhibit
approxim
fig
notabl
found
present
transfect
inhibit
luc
synthesi
much
stronger
molecul
ad
transfect
cell
wash
fresh
medium
condit
translat
capluc
mrna
pv
ire
luc
inhibit
similarli
inhibit
crpv
igrluc
mrna
translat
occur
emcv
ire
luc
mrna
translat
block
concentr
inhibitor
increas
inhibitor
concentr
abolish
translat
mrna
except
case
crpv
igrluc
mrna
inhibit
translat
total
abrog
mrna
test
inhibitor
ad
transfect
mixtur
fig
possibl
explan
result
could
enter
effici
cell
undergo
transfect
ensur
complex
devoid
inhibitori
translat
protein
present
cell
cleav
pv
pro
end
cell
transfect
mrna
encod
pv
pro
h
virtual
cleav
fig
transfect
pv
ire
luc
mrna
follow
addit
indic
mrna
translat
strongli
inhibit
approxim
absenc
pv
pro
howev
cleav
sampl
process
measur
luciferas
activ
b
c
repres
valu
obtain
pv
ire
luc
emcv
ire
luc
crpv
igr
ire
luc
capluc
mrna
respect
rlu
obtain
absenc
inhibitor
respect
valu
consid
control
graph
error
bar
indic
standard
deviat
sd
obtain
least
three
independ
experi
inhibit
reduc
approxim
ad
transfect
profound
arrest
pv
ire
luc
mrna
translat
irrespect
presenc
absenc
pv
pro
fig
therefor
could
block
translat
pv
ire
luc
mrna
cell
despit
cleavag
indic
inhibit
take
place
mechan
differ
abrog
activ
requir
eif
may
differ
cell
infect
virus
compar
translat
mrna
transfect
cell
cell
free
system
sanz
et
al
welnowska
et
al
therefor
effect
next
analyz
cell
infect
anim
virus
principl
employ
purpos
cell
infect
sv
vsv
emcv
case
employ
concentr
rang
cellular
mrna
translat
sensit
inhibit
note
cell
treat
lipofectamin
indic
previous
inhibitor
presum
enter
cell
much
better
presenc
transfect
wherea
cell
refractori
entri
lipofectamin
treatment
fig
fig
show
diminish
protein
synthesi
control
cell
inhibit
increas
similar
inhibit
translat
found
sv
vsv
fig
c
respect
emcv
protein
synthesi
resist
fig
howev
inhibit
emcv
translat
observ
sinc
none
three
anim
virus
requir
infect
conclud
inhibit
viral
mrna
translat
due
lack
interact
cell
recov
luciferas
activ
measur
rlu
obtain
absenc
inhibitor
respect
valu
consid
control
graph
error
bar
indic
sd
obtain
least
three
independ
experi
b
cell
transfect
h
pv
ire
luc
emcv
ire
luc
crpv
igr
ire
luc
capluc
mrna
differ
concentr
ad
transfect
mixtur
cell
wash
incub
fresh
medium
absenc
presenc
inhibitor
min
cell
recov
luciferas
activ
measur
rlu
obtain
absenc
inhibitor
respect
valu
consid
control
graph
error
bar
indic
sd
obtain
least
three
independ
experi
c
cell
transfect
emc
ire
pro
mrna
presenc
absenc
h
induc
cleavag
cell
transfect
pv
ire
luc
h
condit
case
cell
wash
incub
min
final
cell
harvest
measur
luciferas
activ
rlu
obtain
absenc
inhibitor
absenc
pv
pro
presenc
viral
proteas
valu
consid
control
graph
black
bar
gray
bar
repres
incub
inhibitor
transfect
white
bar
repres
transfect
presenc
inhibitor
error
bar
indic
sd
obtain
least
three
independ
experi
western
blot
analysi
use
specif
antibodi
carri
assess
eifgi
cleavag
test
possibl
affect
synthesi
stabil
viral
mrna
examin
incorpor
h
uridin
sv
vsv
emcvinfect
cell
presenc
actinomycin
viral
protein
synthesi
strongli
inhibit
svinfect
cell
approxim
lesser
extent
vsv
emcvinfect
cell
fig
concentr
compound
littl
effect
cellular
rna
synthesi
control
cell
absenc
actinomycin
viral
rna
synthesi
presenc
inhibitor
fig
upper
lower
panel
respect
moreov
synthesi
stabil
sv
sgmrna
translat
late
infect
emcv
rna
similar
cell
treat
conclus
inhibit
sv
emcv
protein
synthesi
compound
due
blockad
synthesi
viral
mrna
degrad
previou
work
demonstr
cellular
protein
synthesi
inhibit
concentr
chang
interact
sever
factor
bind
mcmahon
et
al
found
treatment
cell
differ
concentr
alter
amount
stabil
three
compon
name
fig
addit
immunoprecipit
use
specif
rabbit
polyclon
antibodi
coimmunoprecipit
bhk
cell
extract
coprecipit
observ
antibodi
omit
fig
furthermor
partial
inhibit
coimmunoprecipit
found
wherea
potent
blockad
interact
result
concentr
fig
c
lower
concentr
compound
effect
interact
cell
despit
fact
cellular
translat
strongli
block
concentr
fig
final
cellular
distribut
examin
cell
treat
two
differ
concentr
inhibitor
observ
fig
coloc
bhk
cell
even
treatment
indic
prevent
interact
alter
intracellular
distribut
previou
work
well
current
find
indic
interf
translat
direct
irescontain
mrna
moerk
et
al
result
togeth
observ
cellular
protein
synthesi
block
concentr
affect
interact
mcmahon
et
al
suggest
inhibitor
function
still
unidentifi
step
initi
elong
test
inhibit
elong
phase
translat
cell
measur
synthesi
cellular
protein
short
time
period
min
condit
protein
label
radioact
methionin
due
mainli
elong
thu
cycloheximid
potent
block
protein
synthesi
condit
fig
lane
hippuristanol
concentr
affect
translat
fig
lane
preincub
bhk
cell
hippuristanol
h
radioact
label
strongli
block
cellular
protein
synthesi
fig
lane
present
min
signific
inhibit
translat
inhibit
greater
compound
preincub
h
prior
protein
label
fig
lane
lane
respect
thu
diminish
protein
synthesi
inhibit
compound
preincub
h
find
show
partial
inhibitori
effect
elong
protein
synthesi
asid
blockad
initi
mrna
translat
search
new
translat
inhibitor
produc
recent
year
sever
promis
compound
select
block
process
initi
level
case
hippuristanol
specif
abrog
activ
bordeleau
et
al
garciamoreno
et
al
lindqvist
et
al
recent
describ
inhibitor
initi
includ
interfer
bind
also
abrog
interact
cencic
et
al
also
decreas
coronaviru
replic
cencic
et
al
present
work
analyz
efficaci
protein
synthesi
inhibitor
mrna
translat
differ
anim
virus
curious
describ
inhibitor
block
interact
stimul
bind
moerk
et
al
result
suggest
bind
region
may
overlap
distinct
cencic
et
al
therefor
exact
mechan
action
inhibitor
regard
interact
well
consequ
biolog
effect
may
differ
import
precis
establish
mechan
action
compound
protein
synthesi
sinc
increasingli
use
analyz
sever
cellular
viral
function
inde
exhibit
interest
antivir
antitumor
activ
chen
et
al
mcmahon
et
al
moreov
compound
also
promis
activ
mice
model
autism
previou
work
interpret
mode
action
reveal
compound
block
translat
concentr
disrupt
complex
mcmahon
et
al
good
agreement
result
also
describ
work
cellular
translat
block
concentr
lower
requir
block
interact
regard
present
find
clearli
demonstr
restrict
protein
synthesi
despit
fact
supposedli
particip
translat
viral
mrna
shown
inhibitor
strongli
block
vitro
translat
direct
pv
ire
luc
mrna
process
would
necessari
furthermor
inhibit
similar
remain
intact
cleavag
picornaviru
proteas
sever
domain
recogn
molecular
analysi
marcotrigiano
et
al
ntermin
onethird
respons
interact
twothird
particip
iresdriven
translat
sever
mrna
de
gregorio
et
al
pestova
et
al
picornaviru
proteas
hrv
pv
pro
proteolyt
cleav
releas
ntermin
one
third
factor
belsham
castello
et
al
translat
mrna
bear
emcv
pv
ire
take
place
effici
presenc
distal
twothirdscontain
cterminu
castello
et
al
hundsdoerf
et
al
pestova
et
al
condit
requir
translat
therefor
picornaviru
proteas
particularli
use
analyz
select
inhibitor
interact
present
observ
demonstr
impair
pv
iresdriven
translat
presenc
picornaviru
pro
clearli
indic
molecul
affect
step
translat
process
differ
activ
addit
find
block
vsv
sv
sgmrna
translat
add
support
assert
well
establish
initi
mrna
translat
vsvinfect
cell
independ
intact
complex
connor
lyle
welnowska
et
al
also
observ
translat
sv
sgmrna
castello
et
al
sanz
et
al
propos
inhibitori
activ
could
mediat
accumul
phosphoryl
initi
complex
mcmahon
et
al
presenc
inact
initi
complex
togeth
complex
may
reflect
impair
recycl
eif
inhibit
recycl
eif
may
account
inhibitori
effect
pv
iresdriven
translat
describ
work
translat
sv
sgmrna
take
place
even
phosphoryl
induc
sever
compound
sanz
et
al
moreov
picornaviru
translat
occur
even
becom
phosphoryl
particularli
cleav
picornaviru
proteas
redondo
et
al
welnowska
et
al
even
though
translat
mrna
independ
potent
block
sv
picornaviru
mrna
translat
part
inhibit
could
due
interfer
inhibitor
elong
phase
protein
synthesi
also
interfer
recycl
initi
factor
due
accumul
initi
complex
bear
phosphoryl
could
account
inhibitori
effect
initi
phase
hand
activ
elong
account
decreas
observ
translat
direct
iress
crpv
emcv
moerk
et
al
effect
stabil
compon
interact
cell
cell
treat
indic
concentr
min
cell
monolay
dissolv
sampl
buffer
analyz
sdspage
protein
analyz
western
blot
use
specif
antibodi
describ
materi
method
b
parallel
cell
treat
min
cell
lysat
subject
immunoprecipit
antibodi
specif
associ
analyz
western
blot
use
antibodi
upper
panel
c
bar
chart
repres
quantif
immunoprecipit
protein
western
blot
upper
panel
shown
bhk
cell
seed
glass
coverslip
treat
min
mm
cell
fix
permeabil
process
immunofluoresc
use
green
red
antibodi
nuclei
stain
blue
imag
acquir
confoc
microscop
subsequ
process
huygen
softwar
knowledg
low
concentr
block
initi
translat
would
suggest
two
distinct
process
take
place
one
process
would
blockad
interact
high
concentr
step
involv
inhibit
mechan
remain
determin
futur
studi
direct
uncov
exact
mode
action
addit
assess
activ
recent
describ
select
translat
inhibitor
viral
protein
synthesi
babi
hamster
cell
obtain
atcc
virus
employ
infect
sindbi
viru
sv
vesicular
stomat
viru
vsv
encephalomyocard
viru
emcv
infect
carri
multipl
infect
pfucel
cell
grown
co
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
calf
serum
fc
viral
infect
cell
carri
dmem
without
serum
h
medium
remov
cell
wash
pb
infect
continu
dmem
fc
h
min
case
mock
sv
vsv
infect
h
min
emcv
infect
plasmid
encod
emcv
pv
ire
luc
describ
previous
plasmid
bear
emcv
ire
element
correspond
gene
plasmid
rluc
igrfluc
pigr
crpvluc
kindli
provid
p
sarnow
stanford
univers
usa
cell
transfect
use
lipofectamin
invitrogen
cell
transfect
cotransfect
indic
vitro
transcrib
mrna
rna
ad
togeth
lipofectamin
per
well
optimem
medium
invitrogen
incub
h
lipofectaminecontain
medium
remov
cell
supplement
fresh
medium
fc
protein
synthesi
analyz
indic
time
replac
growth
media
dmem
without
methionin
cystein
supplement
easytag
express
protein
label
mix
metci
perkin
elmer
cell
collect
sampl
buffer
boil
min
analyz
autoradiographi
sdspolyacrylamid
gel
protein
synthesi
quantifi
densitometri
use
calibr
densitomet
biorad
ppvluc
pksluc
pigr
crpvluc
linear
prior
vitro
transcript
rna
polymeras
biolab
accord
manufactur
instruct
plasmid
pksluc
incub
cap
analog
obtain
capluc
mrna
vitro
translat
carri
rabbit
reticulocyt
lysat
rrl
promega
ensur
cleavag
lysat
preincub
min
ngml
purifi
human
rhinoviru
hrv
pro
footandmouth
diseas
viru
fmdv
l
pro
protein
indic
purifi
proteas
kindli
provid
skern
max
f
perutz
laboratori
austria
extract
treat
differ
concentr
calbiochem
plu
addit
ng
mrna
follow
incub
min
protein
synthesi
estim
measur
luciferas
activ
cleavag
determin
western
blot
analysi
viral
rna
synthesi
radioact
label
h
uridin
incorpor
cell
infect
sv
vsv
emcv
determin
describ
sanz
et
al
briefli
cell
infect
treat
actinomycin
hpi
case
sv
vsv
hpi
emcv
h
uridin
ad
h
presenc
absenc
final
total
rna
extract
use
rnaeasi
kit
qiagen
rna
process
detect
viral
rna
synthesi
agaros
gel
electrophoresi
measur
radioact
scintil
counter
follow
treatment
indic
concentr
min
cell
wash
pb
lyse
ripa
buffer
tri
hcl
ph
nacl
sd
triton
mm
pmsf
sodium
desoxychol
cell
lysat
immunoprecipit
antibodi
dilut
use
dynabead
coupl
protein
invitrogen
accord
manufactur
direct
fixat
permeabil
confoc
microscopi
perform
describ
madan
et
al
employ
confoc
len
coupl
axio
imag
microscop
zeiss
oil
planapochromat
object
primari
antibodi
use
rabbit
polyclon
mous
monoclon
santa
cruz
biotechnolog
inc
dilut
specif
antibodi
conjug
alexa
alexa
respect
invitrogen
use
secondari
antibodi
dilut
invitrogen
use
dilut
imag
process
huygen
softwar
scientif
volum
imag
bv
transfect
cell
collect
sampl
buffer
boil
analyz
sdspage
electrophoresi
protein
transfer
nitrocellulos
membran
describ
previous
barco
carrasco
detect
rabbit
antibodi
ntermin
ctermin
moieti
protein
use
dilut
detect
mous
monoclon
antibodi
santa
cruz
biotechnolog
inc
use
dilut
incub
primari
antibodi
perform
h
membran
wash
three
time
pb
contain
incub
h
horseradish
peroxidaseconjug
antirabbit
igg
antibodi
amersham
dilut
wash
three
time
protein
band
visual
ecl
detect
system
amersham
cell
recov
buffer
contain
mm
glycylglycin
ph
triton
mm
dithiothreitol
luciferas
activ
determin
use
luciferas
assay
system
promega
monolight
luminomet
analyt
luminesc
laboratori
describ
previous
alvarez
et
al
ventoso
et
al
